Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The present invention describes cytotoxic compounds with an intracellular target that can selectively enter tumor cells through specific receptors on the cell surface. More
This newly discovered function of MUC1 presents a novel target for the development of new cancer therapies and diagnostics. More
Bio-mimicking (3D cell culture) research tools for drug development More
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2010 - 19 pages - $99
Jul 2011 - 92 pages - $2,000
Nov 2010 - 324 pages - $1,495
Jul 2011 - 133 pages - $500
Feb 2011 - 128 pages - $500
Nov 2010 - 26 pages - $125
Nov 2009 - $15,200
Oct 2010 - 71 pages - $2,000
Nov 2010 - 67 pages - $1,000
Nov 2010 - 40 pages - $500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Adenocarcinoma
- Squamous cell carcinoma
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us